Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue FEBS Letters Année : 2007

Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets.

Résumé

Hsp27 and alphaB-crystallin are molecular chaperones that are constitutively expressed in several mammalian cells, particularly in pathological conditions. These proteins share functions as diverse as protection against toxicity mediated by aberrantly folded proteins or oxidative-inflammation conditions. In addition, these proteins share anti-apoptotic properties and are tumorigenic when expressed in cancer cells. This review summarizes the current knowledge about Hsp27 and alphaB-crystallin and the implications, either positive or deleterious, of these proteins in pathologies such as neurodegenerative diseases, myopathies, asthma, cataracts and cancers. Approaches towards therapeutic strategies aimed at modulating the expression and/or the activities of Hsp27 and alphaB-crystallin are presented.

Dates et versions

hal-00193391 , version 1 (03-12-2007)

Identifiants

Citer

André-Patrick Arrigo, Stéphanie Simon, Benjamin Gibert, Carole Kretz-Remy, Mathieu Nivon, et al.. Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets.. FEBS Letters, 2007, 581 (19), pp.3665-74. ⟨10.1016/j.febslet.2007.04.033⟩. ⟨hal-00193391⟩
268 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More